Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.
U.S. Food and Drug Administration (FDA) approves Zytiga for late-stage prostate cancer – The U.S. Food and Drug Administration approved Zytiga (abiraterone acetate) in combination with prednisone (a steroid) to treat patients with late-stage (metastatic) castration-resistant prostate cancer who have received prior docetaxel (chemotherapy).
New technique extends cancer-fighting cells’ potency in melanoma patients – Researchers trained white blood cells to attack tumors tend to fade away quickly when injected into cancer patients.
Activation of Biomarker Appears Associated With Improved Survival Among Obese Patients With Colorectal Cancer – Among obese patients, activation of the protein biomarker CTNNB1 was associated with better colorectal cancer-specific survival and overall survival, whereas post-diagnosis physical activity was associated with better colorectal cancer-specific survival among patients negative for CTNNB1.
High percentage of omega-3s in the blood may boost risk of aggressive prostate cancer — Conversely, high percentage of trans-fatty acids linked with lower risk – The largest study ever to examine the association of dietary fats and prostate cancer risk has found what’s good for the heart may not be good for the prostate.
Acupuncture relieves hot flashes from prostate cancer treatment – Acupuncture provides long-lasting relief to hot flashes, heart palpitations and anxiety due to side effects of the hormone given to counteract testosterone, the hormone that induces prostate cancer, according to a study published in the April issue of the International Journal of Radiation Oncology?Biology?Physics, an official journal of the American Society for Radiation Oncology (ASTRO).
Study suggests another look at testosterone-prostate cancer link – The long-standing prohibition against testosterone therapy in men with untreated or low-risk prostate cancer merits reevaluation, according to a new study published in The Journal of Urology.
Closely monitoring low-risk prostate cancer, with biopsy, does not raise risk of death and discourages overtreatment – A Johns Hopkins study of 769 men from across the United States recently diagnosed with low-grade prostate cancer shows that forgoing immediate surgery to remove the tumor or radiation poses no added risk of death.
Research shows rapid adoption of newer, more expensive prostate cancer treatments – With 180,000 men diagnosed with prostate cancer each year, it is one of the most common types of cancer in US. For this reason, it has been cited as a good marker for health care spending in general, reflective of the greater trends across the United States.
Breast cancer survivors at higher risk for falls — Cancer therapies may affect balance, according to new study in the Archives of Physical Medicine and Rehabilitation – The combined effects of chemotherapy and endocrine therapy may increase the risk of bone fractures in breast cancer survivors, revealed by researchers in a study.
Researchers identify molecular predictor of metastatic prostate cancer — Finding lays the groundwork for gene-based test – Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups – indolent versus aggressive prostate cancers.
Sprouts? Supplements? Team them up to boost broccoli’s cancer-fighting power – By overcooking their broccoli, many people destroy myrosinase ? a beneficial enzyme in broccoli. Broccoli sprouts contain myrosinase in abundance. To increase the vegetable’s benefits, you must sprinkle broccoli sprouts on your broccoli or make a mustard sauce to serve with broccoli.
Hormone therapy begun at menopause may pose risk for breast cancer – Hormone therapy around menopause is linked to breast cancer risk, revealed by researchers in a study published in The Journal of the National Cancer Institute.
